Respiratory Syncytial Virus and Recurrent Wheeze in Healthy Preterm Infants.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  New England Journal of Medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJMx160016PMID 27305208
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acral melanoma: a unique disease in Asia.

  2013cited by this paper
• Determinants of asthma after severe respiratory syncytial virus bronchiolitis.

  2012cited by this paper
• Spatial relationships between shearing stresses and pressure on the plantar skin surface during gait.

  2012cited by this paper
• The microbiology of asthma

  2012cited by this paper
• Evidence for a causal relationship between respiratory syncytial virus infection and asthma

  2011cited by this paper
• Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life

  2010cited by this paper
• The burden of respiratory syncytial virus infection in young children.

  2009cited by this paper
• The causal direction in the association between respiratory syncytial virus hospitalization and asthma.

  2009cited by this paper
• Season of infant bronchiolitis and estimates of subsequent risk and burden of early childhood asthma.

  2009cited by this paper
• Respiratory Pathogens in Respiratory Tract Illnesses During the First Year of Life: A Birth Cohort Study

  2009cited by this paper
• Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach

  2008cited by this paper
• Evidence of a causal role of winter virus infection during infancy in early childhood asthma.

  2008cited by this paper
• Down Syndrome: A Novel Risk Factor for Respiratory Syncytial Virus Bronchiolitis— A Prospective Birth-Cohort Study

  2007cited by this paper
• Persistence of proinflammatory response after severe respiratory syncytial virus disease in children.

  2007cited by this paper
• Viral specimen collection by parents increases response rate in population-based virus studies.

  2006cited by this paper
• Distinct sets of genetic alterations in melanoma.

  2005cited by this paper
• Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: A longitudinal birth cohort study

  2005cited by this paper
• Impact of Wheezing After Respiratory Syncytial Virus Infection on Health-Related Quality of Life

  2004cited by this paper
• Relationship of viral infections to wheezing illnesses and asthma

  2002cited by this paper
• Survey of respiratory sounds in infants

  2001cited by this paper
• Are all wheezing disorders in very young (preschool) children increasing in prevalence?

  2001cited by this paper
• Medical consumption and socioeconomic effects of infection with respiratory syncytial virus in the Netherlands

  2001cited by this paper
• Long-term consequences of respiratory syncytial virus (RSV) bronchiolitis.

  2000cited by this paper
• Monocyte IL-10 production during respiratory syncytial virus bronchiolitis is associated with recurrent wheezing in a one-year follow-up study.

  2000cited by this paper
• Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years.

  1999cited by this paper
• A case-control study of melanomas of the soles and palms (Australia and Scotland)

  1999cited by this paper
• Assessment and management of foot disease in patients with diabetes.

  1994cited by this paper

• Clinical and economic evaluation of risk factor guided respiratory syncytial virus prophylaxis in Colombian preterm infants

  2026cites this paper
• A Genome Sequence Variant Monitoring Program for Seasonal Influenza A H3N2 and Respiratory Syncytial Virus A using Wastewater-Based Surveillance in Ontario, Canada

  2025influential citation
• Cost-effectiveness of nirsevimab and maternal RSVpreF for preventing respiratory syncytial virus disease in infants across Canada

  2025cites this paper
• MiR-26b-5p and its association with inflammatory markers in infants and toddlers with bronchiolitis and respiratory symptoms

  2025cites this paper
• Exploring parental awareness and willingness to use monoclonal antibodies for respiratory syncytial virus prevention

  2025cites this paper
• Prevention of respiratory syncytial virus disease across the lifespan in Italy

  2025cites this paper
• Surviving prematurity: retrospective longitudinal study of multisystem consequences in preterm-born individuals from infancy to adolescence

  2025cites this paper
• Analysis of the economically justifiable price of nirsevimab to prevent respiratory syncytial virus infection in Korea

  2025cites this paper
• RSV‐Induced Regulation of DC via H3K4 Demethylase KDM5b

  2025cites this paper
• Moderate-to-late prematurity: understanding respiratory consequences and modifiable risk factors

  2025cites this paper
• Brief history of respiratory virus persistence

  2025cites this paper
• B-Raf kinase blockade protects airway epithelial cells against respiratory syncytial virus infection and modulates interferon responses

  2025cites this paper
• Optimal implementation of an Ontario nirsevimab program for respiratory syncytial virus (RSV) prophylaxis: Recommendations from a provincial RSV expert panel

  2024cites this paper
• Bronchiolitis recovery and the use of High Efficiency Particulate Air (HEPA) Filters (The BREATHE Study): study protocol for a multi-center, parallel, double-blind, randomized controlled clinical trial

  2024cites this paper
• Scientific highlights of the 9th ESWI Influenza Conference

  2024cites this paper
• Short‐ and mid‐term morbidity and primary‐care burden due to infant respiratory syncytial virus infection: A Spanish 6‐year population‐based longitudinal study

  2024cites this paper
• The developing immune system in preterm born infants: From contributor to potential solution for respiratory tract infections and wheezing

  2024cites this paper
• Bacteria and viruses and their role in the preschool wheeze to asthma transition

  2024cites this paper
• Effectiveness and efficiency of immunisation strategies to prevent RSV among infants and older adults in Germany: a modelling study

  2024cites this paper
• Nirsevimab: Alleviating the burden of RSV morbidity in young children

  2024cites this paper
• Post-viral lung diseases: the microbiota as a key player

  2024cites this paper
• Effects of palivizumab prophylaxis on respiratory syncytial virus (RSV) infections in Montenegro.

  2024cites this paper
• Consenso de expertos sobre las recomendaciones de profilaxis con palivizumab para el Virus Sincitial Respiratorio en niños en Colombia

  2024cites this paper
• Assessing the long-term economic impact of wheezing episodes after severe RSV disease in children from Argentina: a cost of illness analysis

  2024cites this paper
• Incorporating data from multiple endpoints in the analysis of clinical trials: example from RSV vaccines

  2023cites this paper
• Understanding the increased susceptibility to asthma development in preterm infants

  2023cites this paper
• Are Babies Born Preterm High-Risk Asthma Candidates?

  2023cites this paper
• RSV through the COVID‐19 pandemic: Burden, shifting epidemiology, and implications for the future

  2023cites this paper
• Review of the Safety, Efficacy and Tolerability of Palivizumab in the Prevention of Severe Respiratory Syncytial Virus (RSV) Disease

  2023cites this paper
• Respiratory syncytial virus infection and the need for immunization in Korea

  2023cites this paper
• Role of epithelial barrier function in inducing type 2 immunity following early‐life viral infection

  2023cites this paper
• Metatranscriptome Reveals Specific Immune and Microbial Signatures of Respiratory Syncytial Virus Infection in Children

  2023cites this paper
• Respiratory Syncytial Virus Dominance in Pneumonia Cases After Removal of Pandemic Restrictions

  2023cites this paper
• From preschool wheezing to asthma: Environmental determinants

  2023cites this paper
• Bronchiolitis, Regardless of Its Etiology and Severity, Is Associated With Increased Risk of Asthma: A Population-Based Study

  2023cites this paper
• Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low-income and middle-income countries

  2023cites this paper
• Impact of using the International Risk Scoring Tool on the cost-utility of palivizumab for preventing severe respiratory syncytial virus infection in Canadian moderate-to-late preterm infants

  2023cites this paper
• Respiratory syncytial virus infection and novel interventions

  2023cites this paper
• Respiratory Syncytial Virus (RSV) Hospital Admission Rates and Patients' Characteristics Before the Age of Two in England, 2015-2019

  2023cites this paper
• Model-estimated impacts of pediatric respiratory syncytial virus prevention programs in Mali on asthma prevalence

  2023cites this paper
• New perspectives on respiratory syncytial virus surveillance at the national level: lessons from the COVID-19 pandemic

  2023cites this paper
• Current and emerging pharmacotherapy for respiratory syncytial virus (RSV) infection in infants

  2023cites this paper
• Clinical and economic hospital burden of acute respiratory infection (BARI) due to respiratory syncytial virus in Spanish children, 2015–2018

  2023cites this paper
• Incorporating Data from Multiple Endpoints in the Analysis of Clinical Trials: Example from RSV Vaccines

  2023cites this paper
• Lung Science Conference highlights 2023: Post-viral lung diseases – from basic immunology to clinical phenotypes and therapy

  2023cites this paper
• Diabetes and bacterial co-infection are two independent risk factors for respiratory syncytial virus disease severity

  2023cites this paper
• Prematurity associated wheeze: Current knowledge and opportunities for further investigation

  2022cites this paper
• The burden and surveillance of RSV disease in young children in Belgium—expert opinion

  2022cites this paper
• Burden and severity of children's hospitalizations by respiratory syncytial virus in Portugal, 2015–2018

  2022cites this paper
• RSV Prevention in All Infants: Which Is the Most Preferable Strategy?

  2022cites this paper
• Real-World Studies of Respiratory Syncytial Virus Hospitalizations among Moderate/Late Preterm Infants Exposed to Passive Immunoprophylaxis with Palivizumab

  2022cites this paper
• Communicable Diseases Intelligence The 2018 annual cost burden for children under five years of age hospitalised with respiratory syncytial virus in Australia

  2022cites this paper
• Asthma Guideline Updates

  2022cites this paper
• RSV disease in infants and young children: Can we see a brighter future?

  2022cites this paper
• Nasal DNA methylation at three CpG sites predicts childhood allergic disease

  2022cites this paper
• Lifelong Lung Sequelae of Prematurity

  2022cites this paper
• Respiratory syncytial virus, recurrent wheeze and asthma: A narrative review of pathophysiology, prevention and future directions

  2022cites this paper
• Challenges in Maximizing Impacts of Preventive Strategies against Respiratory Syncytial Virus (RSV) Disease in Young Children

  2022cites this paper
• Respiratory Follow Up of the Premature Neonates—Rationale and Practical Issues

  2022cites this paper
• The impact of COVID-19 pandemic on bronchiolitis (lower respiratory tract infection) due to respiratory syncytial virus: A systematic review and meta-analysis

  2022cites this paper
• Immune determinants of chronic sequelae after respiratory viral infection

  2022influential citation
• Analysing the protection from respiratory tract infections and allergic diseases early in life by human milk components: the PRIMA birth cohort

  2022cites this paper
• Effects of non‐steroidal anti‐inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID‐19

  2022cites this paper
• Nirsevimab: An Extended Half-life Monoclonal Antibody for the Prevention of Infant Respiratory Syncytial Virus Infection

  2021cites this paper
• Palivizumab immunoprophylaxis for infants with BPD has medium- and long-term benefits: myth or maxim?

  2021cites this paper
• Alveolar-like Macrophages Attenuate Respiratory Syncytial Virus Infection

  2021cites this paper
• Effectiveness and cost-effectiveness of RSV infant and maternal immunization programs: A case study of Nunavik, Canada

  2021cites this paper
• Comparison of immune response to human rhinovirus C and respiratory syncytial virus in highly differentiated human airway epithelial cells

  2021cites this paper
• Guidance for palivizumab prophylaxis and implications for compliance

  2021cites this paper
• Common infectious morbidity and white blood cell count in middle childhood predict behavior problems in adolescence

  2021cites this paper
• Economic and disease burden of RSV-associated hospitalizations in young children in France, from 2010 through 2018

  2021cites this paper
• An Outbreak of RSV Infections in the Neonatology Clinic of the University Obstetrics and Gynecology Hospital, Sofia, 2019 – a Case Series

  2021cites this paper
• Infant RSV immunoprophylaxis changes nasal epithelial DNA methylation at 6 years of age

  2021cites this paper
• Pulmonary mesenchymal stem cells are engaged in distinct steps of host response to respiratory syncytial virus infection

  2021cites this paper
• The Future of Respiratory Syncytial Virus Disease Prevention and Treatment

  2021cites this paper
• Strategies for active and passive pediatric RSV immunization

  2021cites this paper
• Socioeconomic Impact of RSV Hospitalization

  2021cites this paper
• Current State of Respiratory Syncytial Virus Disease and Management

  2021cites this paper
• Infant RSV immunoprophylaxis changes nasal epithelial DNA methylation at six years of age

  2021influential citation
• Antibiotic therapy versus no antibiotic therapy for children aged 2 to 59 months with WHO-defined non-severe pneumonia and wheeze.

  2021cites this paper
• Passive Immunoprophylaxis against Respiratory Syncytial Virus in Children: Where Are We Now?

  2021cites this paper
• An outbreak of RSV infections in a neonatology clinic during the RSV-season

  2021cites this paper
• Early-Life Respiratory Syncytial Virus Infection, Trained Immunity and Subsequent Pulmonary Diseases

  2020cites this paper
• Update on current views and advances on RSV infection (Review)

  2020cites this paper
• TIPICO X: report of the 10th interactive infectious disease workshop on infectious diseases and vaccines

  2020cites this paper
• Evidence on the Link between Respiratory Syncytial Virus Infection in Early Life and Chronic Obstructive Lung Diseases

  2020cites this paper
• Respiratory Syncytial Virus-related Death in Children With Down Syndrome

  2020cites this paper
• Respiratory Syncytial Virus-Associated Hospital Admissions in Children Younger Than 5 Years in 7 European Countries Using Routinely Collected Datasets.

  2020cites this paper
• The Journey to an RSV Vaccine

  2020cites this paper
• COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far

  2020cites this paper
• RSV Lower Respiratory Tract Illness in Infants of Low- and Middle-income Countries.

  2020cites this paper
• TNF-mediated alveolar macrophage necroptosis drives disease pathogenesis during respiratory syncytial virus infection

  2020cites this paper
• Role of Respiratory Syncytial Virus in Pediatric Pneumonia

  2020cites this paper
• Impact of Prematurity and Severe Viral Bronchiolitis on Asthma Development at 6–9 Years

  2020cites this paper
• Epidemiology of Bronchiolitis: Multicentric Study Policlinico-Garibaldi-Bronte-Caltagirone-Siracusa

  2020cites this paper
• Current State and Challenges in Developing Respiratory Syncytial Virus Vaccines

  2020cites this paper
• Characterizing the Genomic Diversity, Evolution and Phylogeography of Respiratory Syncytial Virus Genotype ON1 in Kenya

  2019cites this paper
• Targeting inducible epigenetic reprogramming pathways in chronic airway remodeling

  2019cites this paper
• The Respiratory Mucosa: Front and Center in Respiratory Syncytial Virus Disease

  2019cites this paper
• The role of epigenetics in the development of childhood asthma

  2019cites this paper